Month Timeline - How Cannabis Rescheduling Actually Takes EffectAnnouncementPresident signals intent or issues executive directionDEA RulemakingDEA drafts proposed rule; public notice and comment ...
FDA approval was based on results from the largest Phase 3 clinical trial ever conducted for a new treatment against ...
Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing next-generation ...
Power Metals entered into a cesium concentrate offtake agreement with Albemarle Corporation, a US$16 billion global critical ...
The "Peptide Cancer Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2031" has been added to ResearchAndMarkets.com's offering.The global peptide cancer vaccine market is expected ...
ANKTIVA plus BCG is the first immunotherapy for non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS), with ...
Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced ...
Solutions Market Overview:The global electronic clinical outcome assessment (eCOA) solutions market is expected to grow at a ...
Quincey to Continue as Executive Chairman of the BoardATLANTA--(BUSINESS WIRE)--The Coca-Cola Company today announced that ...
Phase 3 findings show oral zoliflodacin to be non-inferior to the combination of ceftriaxone and azithromycin for the ...
Leadership Changes to Take Effect Following Conclusion of Ordinary General Meeting of Shareholders in March 2026Announcement ...
The Phase 3 STAR-221 study evaluating a domvanalimab-based combination in upper gastrointestinal cancers will be discontinued due to futilityArcus is continuing to expand its development program for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback